InfuSystem Holdings (INFU) Return on Capital Employed (2011 - 2026)
InfuSystem Holdings' (INFU) quarterly Return on Capital Employed came in at 15.63% in Q1 2026, up 614.0% YoY from 2.19% in Q1 2025, and up 4.31% on a QoQ basis from 14.99% in Q4 2025.
InfuSystem Holdings (INFU) Return on Capital Employed (2011 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 16 years of Return on Capital Employed data on file, last reported at 15.63% in Q1 2026.
- Quarterly Return on Capital Employed rose 614.0% year-over-year to 15.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.63% (up 614.0% YoY) and the FY2025 annual result came in at 14.55%, up 650.0% from the prior year.
- Return on Capital Employed rose to 15.63% in Q1 2026, from 14.99% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 15.63% in Q1 2026 to a low of 1.11% in Q2 2022.
- A 5-year average of 6.47% and a median of 4.39% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 1015 bps — and 2025, when it surged 749 bps.
- Tracing INFU's Return on Capital Employed over 5 years: stood at 1.95% in 2022, then jumped by 141 bps to 4.71% in 2023, then surged by 69 bps to 7.94% in 2024, then soared by 89 bps to 14.99% in 2025, then climbed by 4 bps to 15.63% in 2026.
- The last three Return on Capital Employed figures came in at 15.63% (Q1 2026), 14.99% (Q4 2025), and 13.34% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn | 16.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.01% |
| Mar 31, 2026 | 15.63% |
| Dec 31, 2025 | 14.99% |
| Sep 30, 2025 | 13.34% |
| Jun 30, 2025 | 11.85% |
| Mar 31, 2025 | 9.50% |
| Dec 31, 2024 | 7.94% |
| Sep 30, 2024 | 6.14% |
| Jun 30, 2024 | 4.36% |
| Mar 31, 2024 | 3.87% |
| Dec 31, 2023 | 4.71% |
| Sep 30, 2023 | 4.39% |
| Jun 30, 2023 | 3.47% |
| Mar 31, 2023 | 2.38% |
| Dec 31, 2022 | 1.95% |
| Sep 30, 2022 | 2.58% |
| Jun 30, 2022 | 1.11% |
| Mar 31, 2022 | 1.69% |
| Dec 31, 2021 | 3.39% |
| Sep 30, 2021 | 2.78% |